Florida International University

FIU Digital Commons
Department of Biostatistics Faculty
Publications

Robert Stempel College of Public Health &
Social Work

10-1-2020

A Clinical Tool to Identify Candidates for Stress-First Myocardial
Perfusion Imaging
Soroush Rouhani
Institut de Cardiologie de l'Université d'Ottawa

Ali Al Shahrani
Institut de Cardiologie de l'Université d'Ottawa

Alomgir Hossain
Institut de Cardiologie de l'Université d'Ottawa

Yeung Yam
Institut de Cardiologie de l'Université d'Ottawa

R. Glenn Wells
Institut de Cardiologie de l'Université d'Ottawa

See next page for additional authors
Follow this and additional works at: https://digitalcommons.fiu.edu/biostatistics_fac

Recommended Citation
Rouhani, Soroush; Al Shahrani, Ali; Hossain, Alomgir; Yam, Yeung; Wells, R. Glenn; deKemp, Robert A.;
Beanlands, Rob S.; Ruddy, Terrence D.; Di Carli, Marcelo F.; Merhige, Michael E.; Williams, Brent A.; Veledar,
Emir; Berman, Daniel S.; Dorbala, Sharmila; and Chow, Benjamin J.W., "A Clinical Tool to Identify
Candidates for Stress-First Myocardial Perfusion Imaging" (2020). Department of Biostatistics Faculty
Publications. 76.
https://digitalcommons.fiu.edu/biostatistics_fac/76

This work is brought to you for free and open access by the Robert Stempel College of Public Health & Social Work
at FIU Digital Commons. It has been accepted for inclusion in Department of Biostatistics Faculty Publications by
an authorized administrator of FIU Digital Commons. For more information, please contact dcc@fiu.edu.

Authors
Soroush Rouhani, Ali Al Shahrani, Alomgir Hossain, Yeung Yam, R. Glenn Wells, Robert A. deKemp, Rob S.
Beanlands, Terrence D. Ruddy, Marcelo F. Di Carli, Michael E. Merhige, Brent A. Williams, Emir Veledar,
Daniel S. Berman, Sharmila Dorbala, and Benjamin J.W. Chow

This article is available at FIU Digital Commons: https://digitalcommons.fiu.edu/biostatistics_fac/76

JACC: CARDIOVASCULAR IMAGING

VOL. 13, NO. 10, 2020

ª 2020 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION
PUBLISHED BY ELSEVIER

ORIGINAL RESEARCH

A Clinical Tool to Identify Candidates
for Stress-First Myocardial
Perfusion Imaging
Soroush Rouhani, BSC,a Ali Al Shahrani, MD, MSC,a,b Alomgir Hossain, PHD,c Yeung Yam, BSC,a R. Glenn Wells, PHD,a
Robert A. deKemp, PHD,a Rob S. Beanlands, MD,a,d Terrence D. Ruddy, MD,a,d Marcelo F. Di Carli, MD,e,f
Michael E. Merhige, MD,g Brent A. Williams, PHD,h Emir Veledar, PHD,i Daniel S. Berman, MD,j
Sharmila Dorbala, MD, MPH,e,f Benjamin J.W. Chow, MDa,d

ABSTRACT
OBJECTIVES This study sought to develop a clinical model that identiﬁes a lower-risk population for coronary artery
disease that could beneﬁt from stress-ﬁrst myocardial perfusion imaging (MPI) protocols and that can be used at point of
care to risk stratify patients.
BACKGROUND There is an increasing interest in stress-ﬁrst and stress-only imaging to reduce patient radiation
exposure and improve patient workﬂow and experience.
METHODS A secondary analysis was conducted on a single-center cohort of patients undergoing single-photon emission computed tomography (SPECT) and positron emission tomography (PET) studies. Normal MPI was deﬁned by the
absence of perfusion abnormalities and other ischemic markers and the presence of normal left ventricular wall motion
and left ventricular ejection fraction. A model was derived using a cohort of 18,389 consecutive patients who underwent
SPECT and was validated in a separate cohort of patients who underwent SPECT (n ¼ 5,819), 1 internal cohort of patients
who underwent PET (n¼4,631), and 1 external PET cohort (n ¼ 7,028).
RESULTS Final models were made for men and women and consisted of 9 variables including age, smoking, hypertension, diabetes, dyslipidemia, typical angina, prior percutaneous coronary intervention, prior coronary artery bypass
graft, and prior myocardial infarction. Patients with a score #1 were stratiﬁed as low risk. The model was robust with
areas under the curve of 0.684 (95% conﬁdence interval [CI]: 0.674 to 0.694) and 0.681 (95% CI: 0.666 to 0.696) in
the derivation cohort, 0.745 (95% CI: 0.728 to 0.762) and 0.701 (95% CI: 0.673 to 0.728) in the SPECT validation
cohort, 0.672 (95% CI: 0.649 to 0.696) and 0.686 (95% CI: 0.663 to 0.710) in the internal PET validation cohort, and
0.756 (95% CI: 0.740 to 0.772) and 0.737 (95% CI: 0.716 to 0.757) in the external PET validation cohort in men and
women, respectively. Men and women who scored #1 had negative likelihood ratios of 0.48 and 0.52, respectively.
CONCLUSIONS A novel model, based on easily obtained clinical variables, is proposed to identify patients with low
probability of having abnormal MPI results. This point-of-care tool may be used to identify a population that might
qualify for stress-ﬁrst MPI protocols. (J Am Coll Cardiol Img 2020;13:2193–202) © 2020 by the American College of
Cardiology Foundation.
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ABBREVIATIONS
AND ACRONYMS
3D = 3-dimensional
ASNC = American Society of
Nuclear Cardiology

AUC = area under the curve
BMI = body mass index
CAD = coronary artery disease
CI = conﬁdence interval
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T A B L E 1 Baseline Characteristics of the Derivation Cohort

Age, yrs

All Comers
(N ¼ 18,389)

Normal SPECT
(n ¼ 11,712)

Abnormal SPECT
(n ¼ 6,677)

p Value

63.9  11.8

63.1  11.7

65.21  11.8

<0.001

images were acquired in adherence to the ASNC

BMI, kg/m2

28.4  5.7

28.3  5.6

28.6  5.7

0.001

guidelines. Technetium-99m tetrofosmin radiotracer

Male

10,641 (57.8)

5,684 (48.4)

4,981 (74.4)

<0.001

was used with standard rest-stress SPECT protocols as

Hypertension

11,586 (62.9)

6,768 (57.6)

4,824 (72.1)

<0.001

per ASNC guidelines (9). Images were acquired using

Diabetes

3,842 (20.9)

2,086 (17.8)

1,758 (26.3)

<0.001

either dual-headed Na-I gamma cameras (Inﬁnia with

Hyperlipidemia

10,507 (57.1)

5,956 (50.7)

4,572 (68.3)

<0.001

Hawkeye [GE Healthcare, Waukesha, Wisconsin] and

Current smoking

3,093 (16.8)

1,829 (15.6)

1,273 (19.0)

<0.001

Past smoking

6,512 (35.4)

3,900 (33.2)

2,624 (39.2)

<0.001

Family history

7,008 (38.1)

4,465 (38.0)

2,555 (38.2)

0.887

History of PCI

3,063 (16.6)

1,177 (10.0)

1,885 (28.2)

<0.001

e-CAM [Siemens Medical Systems, Siemens Healthineers AG, Erlangen, Germany]), or cadmium-zinctelluride (CZT) cameras (Discovery NM, 530c, GE

History of CABG

1,396 (7.6)

404 (3.4)

993 (14.8)

<0.001

Healthcare) (Supplemental Table 1). The derivation

History of MI

3,355 (18.2)

1,091 (9.3)

2,264 (33.8)

<0.001

cohort consisted of a mixture of full-dose studies

Typical angina

3,184 (17.3)

1,972 (16.8)

1,221 (18.2)

0.014

until February 2012 and primarily half-dose studies

Pre-test probability

31.8  31.3

30.3  30.4

34.3  32.6

<0.001

after that date. For full-dose studies, the injected

Dyspnea

9,548 (51.9)

6,012 (51.3)

3,531 (52.9)

0.044

radiotracer activity was 300 MBq (8.1 mCi) at rest and
1,000 MBq (27 mCi) at stress for body mass index
(BMI) <30 (male patients) or <25 (female patients)

Values are mean  SD or n (%). The p values correspond to the comparison of normal vs. abnormal myocardial
perfusion imaging subgroups.
BMI ¼ body mass index; CABG ¼ coronary artery bypass graft; MI ¼ myocardial infarction; PCI ¼ percutaneous
coronary intervention; SPECT ¼ single-photon emission computed tomography.

and increased to 350 MBq (9.5 mCi) at rest and 1,100
MBq (29.7 mCi) at stress for larger BMI patients. For
BMI >30 (female patients) or >35 (male patients), a 2day protocol was used with 1,100 MBq (29.7 mCi)
injected at both rest and stress. The half-dose protocol used exactly one-half of the full-dose activity
amounts.
Dual-headed gamma cameras used parallel-hole
low-energy high-resolution collimators and acquired
images at 25 s per projection for 60 (Inﬁnia) or 64 (eCAM) projections over 180 for both rest and stress

The CZT camera used 19 pinhole collimators and
acquired stress and rest images for 3 and 5 min,
respectively, for full-dose studies, or 6 and 10 min,
respectively,

when

half-dose

protocols

were

employed. Maximum a posteriori EM software (40
iterations for rest or 50 iterations for stress) and 3D
Butterworth ﬁltering (order 7, 0.37 cycles/cm) were
used for image reconstruction.

images (full-dose protocol). For the half-dose proto-

PET

col, acquisition times were changed to 30 s per pro-

images were acquired using a Discovery 690 or 600

IMAGE

ACQUISITION

jection (rest) and 20 s per projection (stress). Studies

PET-CT scanner (GE Healthcare) with low-dose CT

performed at full-dose tracer with the Inﬁnia camera

attenuation

were reconstructed using an ordered-subset expec-

Weight-based dosing of 8 to 10 MBq/kg rubidium-82

tation maximization (OSEM) algorithm (2 iterations

was used at rest and stress per ASNC guidelines.

and 10 subsets for stress, 3 iterations and 4 subsets for

Dynamic PET imaging was started with the initial

correction

PROTOCOL. PET

scans

acquired

at

MPI

rest.

rest), whereas half-dose Inﬁnia images were recon-

arrival of activity in the scanner ﬁeld of view. Static

structed with a maximum a posteriori OSEM algo-

(ungated) images were reconstructed from 2 to

rithm performed with Evolution for Cardiac software

8 min using the vendor iterative program (VuePoint

(GE Healthcare) using 8 iterations and 15 subsets (rest

HD) with 12-mm 3D Hann post-ﬁlter. Electrocardio-

and stress). Post-reconstruction ﬁltering was ach-

gram-gated images (8 bins) were reconstructed from

ieved with 3-dimensional (3D) Butterworth ﬁltering

1.5 to 8 min with 16-mm 3D Hann post-ﬁlter.

(order 10, 0.3 cycles/cm cutoff) for both half-dose and

External cohort PET image acquisition has been

full-dose Inﬁnia studies. The e-CAM images were

previously described (6).

reconstructed using an OSEM algorithm (6 iterations,

MPI INTERPRETATION. Visual analysis of SPECT and

16 subsets, Butterworth 3D ﬁlter with order 5, 0.43

PET images was performed using Corridor-4DM

cycles/cm) with Hermes software (Hermes Medical

version 2012 (INVIA Medical Imaging Solutions, Ann

Solutions, Stockholm, Sweden) until July 2015 after

Arbor, Michigan). Expert observers reviewed MPI

which OSEM with resolution recovery (HRecon; Her-

studies and perfusion defects were graded using a 5-

mes Medical Solutions) was used with 5 iterations and

point scoring system (0 ¼ normal, 1 ¼ mild,

16 subsets and 3D Butterworth ﬁltering (order 5, 0.32

2 ¼ moderate, 3 ¼ severe, 4 ¼ absent tracer uptake) on

cycles/cm cutoff).

a standard 17-segment left ventricular model (7,12).
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T A B L E 2 Baseline Characteristics of the SPECT, UOHI PET, and External PET Validation Cohorts

All Comers

Normal

Abnormal

p Value

SPECT Validation Cohort
(n ¼ 5,819)

(n ¼ 4,025)

(n ¼ 1,794)

Age, yrs

64.8  11.4

64.0  11.3

66.8  11.5

<0.001

Male

3,445 (59.2)

2,099 (52.1)

1,346 (75.0)

<0.001

BMI, kg/m2

28.5  6.3

28.5  6.6

28.4  5.4

Hypertension

3,620 (62.2)

2,244 (55.8)

1,376 (76.7)

Diabetes

1,323 (22.7)

805 (20.0)

518 (28.9)

<0.001

Hyperlipidemia

3,452 (59.3)

2,118 (52.6)

1,334 (74.4)

<0.001

0.620
<0.001

Current smoking

856 (14.7)

548 (13.6)

308 (17.2)

0.001

Past smoking

2,102 (36.1)

1,387 (34.5)

715 (39.9)

<0.001

Family history of
coronary artery disease

2,348 (40.4)

1,607 (39.9)

741 (41.3)

0.296

History of PCI

1,106 (19.0)

466 (11.6)

640 (35.7)

<0.001

History of CABG

462 (7.9)

134 (3.3)

328 (18.3)

<0.001

History of MI

1,044 (17.9)

371 (9.2)

673 (37.5)

<0.001

Typical angina

1,114 (19.1)

693 (17.2)

421 (23.5)

<0.001

Pre-test probability

35.4  31.9

33.4  30.8

39.7  34.0

<0.001

Dyspnea

3,205 (55.1)

2,210 (54.9)

995 (55.5)

0.819

UOHI PET Validation Cohort
(n ¼ 4,631)

(n ¼ 1,766)

(n ¼ 2,865)

Age, yrs

63.9  11.2

60.4  11.1

66.1  10.7

<0.001

Male

2,586 (55.8)

726 (41.1)

1,860 (64.9)

<0.001

31.1  7.5

31.9  8.0

30.6  7.1

<0.001

Hypertension

3,357 (72.5)

1,136 (64.4)

2,221 (77.5)

<0.001

Diabetes

1,405 (30.3)

427 (24.2)

978 (34.1)

<0.001

Hyperlipidemia

3,344 (72.2)

1,117 (63.3)

2,227 (77.7)

<0.001

701 (15.1)

240 (13.6)

461 (16.1)

0.023

Past smoking

2,208 (47.7)

770 (43.6)

1,438 (50.2)

<0.001

Family history of
coronary artery disease

2,519 (54.4)

973 (55.1)

1,546 (54.0)

0.510

History of PCI

1,298 (28.0)

350 (19.9)

948 (33.2)

<0.001

534 (11.5)

87 (4.9)

447 (15.6)

<0.001

History of MI

1,337 (29.6)

275 (16.0)

1,062 (37.9)

<0.001

Typical angina

872 (18.8)

302 (17.1)

570 (19.9)

0.018

BMI, kg/m2

Current smoking

History of CABG

External PET Validation Cohort
(n ¼ 7,028)

(n ¼ 4,766)

(n ¼ 2,262)

Age, yrs

63.3  13.1

61.8  13.1

66.5  12.3

<0.001

Male

3,698 (52.6)

2,207 (46.3)

1,491 (65.9)

<0.001

BMI, kg/m2

30.2  7.3

30.2  7.4

30.0  7.1

Hypertension

4,764 (67.8)

3,077 (64.6)

1,687 (74.6)

<0.001

Diabetes

1,911 (27.2)

1,086 (22.8)

825 (36.5)

<0.001

Hyperlipidemia

4,485 (63.8)

2,876 (60.3)

1,609 (71.1)

<0.001

Smoking history

1,523 (21.7)

963 (20.2)

560 (24.8)

<0.001

History of PCI

1,220 (17.4)

563 (11.8)

657 (29.0)

<0.001

History of CABG

945 (13.4)

339 (7.1)

606 (26.8)

<0.001

History of MI

1,476 (21.0)

532 (11.2)

944 (41.7)

<0.001

Angina or dyspnea

4,523 (64.4)

3,131 (65.7)

1,392 (61.5)

0.174

0.001

Values are mean  SD or n (%). The p values correspond to the comparison of normal vs. abnormal myocardial perfusion imaging subgroups.
PET ¼ positron emission tomography; UOHI ¼ University of Ottawa Heart Institute; other abbreviations as in Table 1.

A normal study was deﬁned as the absence of

ventricular wall motion and left ventricular ejection

perfusion abnormalities or other potential ischemic

fraction. Patients with normal myocardial perfusion

markers (transient ischemic dilatation, right ventric-

but failure to achieve their target heart rate with ex-

ular uptake, etc.), and the presence of normal left

ercise stress were categorized as equivocal.
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ANALYSIS. Statistical

analysis

was

performed using IBM SPSS software version 24 (IBM

T A B L E 3 Multivariate Analysis Predicting Non-Normal SPECT in Men and Women

Corp., Armonk, New York). Using an outcome of
“abnormal” SPECT study interpretation, univariate
analysis was performed on demographic and clinical
variables collected for all patients at time of testing
(13). Using a cutoff of p > 0.20, the variables of age,
BMI, sex, typical angina, current smoking, previous

Beta Coefﬁcient

SE

OR

Lower CI

Upper CI

p Value

Men
Age, yrs
<55

<0.001

0

55–69

0.117

0.054

1.124

1.012

1.249

0.029

70–84

0.286

0.061

1.331

1.181

1.501

<0.001

>85

0.463

0.130

1.589

1.232

2.048

<0.001

smoking, hypertension, diabetes, hyperlipidemia,

Current smoker

0.272

0.054

1.312

1.180

1.459

<0.001

family history of CAD, previous myocardial infarc-

Hypertension

0.163

0.046

1.177

1.074

1.289

<0.001

tion, previous percutaneous coronary intervention,

Diabetes

0.119

0.050

1.126

1.020

1.243

0.018

and previous coronary artery bypass graft were

Previous infarct

1.081

0.060

2.947

2.619

3.316

<0.001

selected for multivariate analysis. In the multivari-

Previous PCI

0.459

0.059

1.582

1.409

1.776

<0.001

Previous CABG

0.867

0.075

2.379

2.054

2.756

<0.001

Typical angina

0.111

0.056

1.118

1.002

1.247

0.905

0.051

0.405

able logistic regression analysis, statistical signiﬁcance was deﬁned as p < 0.05, and variables within
this limit were included in the ﬁnal model. As per the
Framingham

Risk

Score

(14)

and

the

method

Constant

0.046
<0.001

Women
Age, yrs

described by Le Gal et al. (15) for dichotomous vari-

<70

0

0

ables, a scoring system was developed by assigning

70–84

0.292

0.063

1.339

>85

<0.001
1.182

1.516

<0.001
<0.001

0.568

0.131

1.765

1.366

2.280

Current smoker

0.237

0.081

1.267

1.082

1.484

0.003

Hypertension

0.319

0.069

1.376

1.202

1.576

<0.001

Diabetes

0.392

0.073

1.480

1.284

1.706

<0.001

Previous infarct

0.935

0.092

2.547

2.126

3.052

<0.001

interval (CI) to evaluate discrimination ability of the

Previous PCI

0.407

0.101

1.502

1.233

1.830

<0.001

model against other established models.

Previous CABG

1.173

0.141

3.232

2.452

4.261

<0.001

Hyperlipidemia

0.181

0.067

1.198

1.051

1.365

2.055

0.060

0.128

weighted points for each variable, and a total score
was calculated for each patient. A receiver-operating
characteristic curve was generated, and area under
the curve (AUC) was calculated with 95% conﬁdence

RESULTS
A total of 18,389 consecutive rest-stress SPECT MPIs

Constant

CI ¼ conﬁdence interval; OR ¼ odds ratio; other abbreviations as in Table 1.

were used as the derivation cohort with a total of
63.7% interpreted as “normal.” The mean age of this

positive and negative likelihood ratios (Supplemental

cohort was 63.9 years of age with a mean BMI of 28.4

Table 2).

and a male proportion of 57.8% (Table 1). The results

The AUC of the receiver-operating characteristic of

were then validated in a separate cohort of 5,819

the derived model was 0.684 (95% CI: 0.674 to 0.694)

consecutive patients who underwent SPECT with

and 0.681 (95% CI: 0.666 to 0.696) for men and

similar demographic characteristics, as well as a second validation cohort of 4,631 consecutive patients
who underwent PET, and then external validation

T A B L E 4 Clinical Score Model

was performed with a multicenter cohort of 7,028
patients who underwent PET (Table 2).
Based on the multivariable analysis (Table 3), age,

Men

Women

Age, yrs
<55

0

0

sex, typical angina, smoking, hypertension, diabetes,

55–69

1

0

hyperlipidemia, prior coronary artery bypass graft,

70–84

3

1

prior percutaneous coronary intervention, and prior

$85

4

2

Typical angina

1

0

Hyperlipidemia

0

1

Current smoking

2

1
2

myocardial infarction were included in the ﬁnal predictive model (Table 4) and points were assigned
based on regression coefﬁcients. Multivariate anal-

Hypertension

2

ysis for each sex as a subgroup produced 2 very

Diabetes

1

2

similar scoring models, with the only difference being

History of MI

10

5

the inclusion of typical angina in men only (1 point)

History of PCI

4

2

and dyslipidemia in women only (1 point), as well as

History of CABG

8

6

an additional age category in men (55 to 69 years of
age). The predictive probability of an abnormal MPI
was calculated for each score along with respective

0 to 1 ¼ low risk for a non-normal myocardial perfusion imaging.
Abbreviations as in Table 1.

0.007
<0.001
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F I G U R E 1 ROC Curves for Predicting Abnormal SPECT Studies

B

1.0

1.0

0.8

0.8

0.6

0.6

Sensitivity

Sensitivity

A

0.4

0.2

0.4

0.2

0.0

0.0
0.0

0.2

0.4

0.6

0.8

1.0

0.0

0.2

0.4

1-Specificity

0.6

0.8

1.0

1-Specificity

Receiver-operating characteristic (ROC) curves for the clinical score for prediction of abnormal single-photon emission computed tomography (SPECT) studies in male
(A) and female (B) patients. Area under curve for male patients is 0.684 (A) and for female patients is 0.681 (B).

women, respectively (Figure 1). When applied to the

studies. Based on this threshold, the positive and

SPECT validation cohort, the model yielded an AUC of

negative likelihood ratios of having an abnormal

0.747 (95% CI: 0.730 to 0.764) and 0.702 (95% CI:

SPECT study were 1.15 and 0.48 for men, respectively,

0.675 to 0.730) for men and women, respectively. The

and 1.25 and 0.52 for women, respectively. This cutoff

PET validation cohort yielded similar results with an

identiﬁed patients with an abnormal study with a

AUC of 0.672 (95% CI: 0.649 to 0.696) and 0.686

sensitivity of 89.6% in men and 82.2% in women.

(95% CI: 0.663 to 0.710) for men and women,

Conversely, normal studies were identiﬁed with a

respectively. A subanalysis was performed using pa-

speciﬁcity of 70.6% in men and 87.1% in women

tients imaged with CZT and NaI cameras separately.

(Table 5). The predicted and observed probability of

The model performed equally well irrespective of

having an abnormal SPECT per clinical score is pre-

camera type. Another subanalysis showed that the

sented in Figure 2.

model performed equally well in patients with low to

Using this same threshold in the SPECT validation

intermediate-low pre-test probability of CAD, deﬁned

cohort, the positive and negative likelihood ratios

as a pre-test probability of #33.3%. This also held true

and speciﬁcity for identifying abnormal SPECT

in patients with a pre-test probability of #50%.

studies were, respectively, 1.20, 0.29, and 84.5% in

A score of #1 was selected as a threshold based on

men, and 1.35, 0.35, and 92.6% in women. In the

its sensitivity and speciﬁcity of predicting abnormal

PET validation cohort, the positive and negative

T A B L E 5 Patients With High Likelihood of a Normal MPI Study According to Sex

Derivation
Model Score (0-1)

Validation SPECT

Validation PET

Patients

Normal SPECT

Patients

Normal SPECT

Patients

Men

1,763 (16.6)

1,244 (70.6)

542 (15.7)

458 (84.5)

206 (7.9)

112 (54.4)

Women

2,368 (30.5)

2,063 (87.1)

739 (31.1)

684 (92.6)

349 (17.0)

248 (71.6)

Values are n (%).
MPI ¼ myocardial perfusion imaging; other abbreviations as in Table 1.

Normal PET
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F I G U R E 2 Predicted Versus Observed Probability of Abnormal SPECT Studies

A

Probability of Abnormal SPECT vs. Clinical Score (Men)

Probability of Abnormal SPECT (%)
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B

Probability of Abnormal SPECT vs. Clinical Score (Women)

Probability of Abnormal SPECT (%)
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Clinical Score

Predicted (red) versus observed (green) probability of abnormal single-photon emission computed tomography (SPECT) studies in men (A)
and women (B), respectively. Mean observed versus predicted probability plotted for each score range.

likelihood ratios and speciﬁcity were 1.12, 0.33, and

population that is more likely to have a normal MPI

54.4% in men and 1.18, 0.42, and 71.1% in women,

study and thus may be considered for a stress-ﬁrst

respectively. The model performed better in an

protocol. This model could be used at the point of

external cohort of PET patients, with an AUC of 0.752

care to assist with decision making and image

in men and 0.737 in women.

protocoling.

In the derivation cohort, 16.6% of men and 30.5%

Although a score #1 is thought to be strict, this

of women had a score of #1. Similarly in the SPECT

threshold was chosen to minimize abnormal studies.

validation cohort, this score corresponded to 15.7% of

Different institutions may elect to use different

men and 31.1% of women (Table 5).

thresholds,

acknowledging

that

a

higher

score

threshold would result in decreased sensitivity

DISCUSSION

(Central Illustration, Table 6). The threshold of #1
would still be applicable to 16.6% of men and 30.5% of

In a large cohort of 18,389 patients, we derive and

women. Based on the model, men with scores #1 are

validate a model that may be used to identify a

those who are: 1) <70 years of age without cardiac risk
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C E N T R A L IL L U ST R A T I O N Model Score and Proportion of Men and Women With Normal and
Abnormal SPECT Studies

5,000

86.0%

4,500

67.8%

4,000

86.3%

Patients

3,500
3,000

68.8%

2,500
2,000

87.1%

70.6%

88.9%

1,500
1,000

70.3%

500
0

0

≤1

≤2

≤3

0

≤1

Men

≤2

≤3

Women
Score Cut-Offs

Rouhani, S. et al. J Am Coll Cardiol Img. 2020;13(10):2193–202.

Model score and corresponding proportion of men and women with normal (blue) and abnormal (red) single-photon emission computed
tomography (SPECT) studies. Percentage of normal studies indicated for each score.

factors, typical chest pain, or documented CAD or:

study, 29.4% of men and 12.9% of women would

2) <55 years of age with either typical angina or dia-

still require rest imaging. Rest imaging may be

betes mellitus. Similarly, women with a score #1 are

required in a greater proportion because our study

those who are: 1) <85 years of age without cardiac risk

does not account for all factors that would cause

factors, or; 2) <70 years of age with either dyslipide-

stress-perfusion defects (such as artifact, incom-

mia or a smoking history.

plete attenuation correction, inability to reach peak

Although men and women with scores #1 had
70.6% and 87.1% probability of having a normal

heart rate).
The speciﬁcity of the model in SPECT and PET cohorts was different and likely attributable to several

T A B L E 6 Sensitivity and Accuracy of Various Score Thresholds in Men and Women

factors. First, at our center, there exists a referral and

Score Cutoff

patient selection bias between the 2 modalities

Sensitivity

Proportion of Patients

Patients Requiring Rest Imaging

(Table

Men

3).

Furthermore,

the

quantiﬁcation

of

6.9

29.7

myocardial blood ﬂow and myocardial ﬂow reserve

89.6

16.1

29.4

with PET would potentially affect image interpreta-

84.4

23.3

31.2

tion. Also, the higher diagnostic accuracy of PET

#3

73.2

38.9

32.2

#4

could have potentially led to more correct diagnoses

69.4

43.6

32.7

#5

58.3

56.9

34.2

#0

90.8

18.4

11.1

#1

82.2

30.5

12.9

The model was validated against 3 validation co-

#2

72.3

44.7

13.7

horts and proved to have similar or superior perfor-

#3

61.3

60.7

14.0

mance. Differences in its performance characteristics

#4

48.2

73.0

15.6

#5

may be due to differences in population and referral

38.2

80.9

16.8

bias. However, the results reassure us that the model

#0

95.6

#1
#2

Women

Values are %.

in similar patients who would have otherwise been
falsely categorized (false positive or false negative)
with SPECT MPI.

should perform equally well at other institutions with
different populations.
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to

Performing stress-ﬁrst studies does not detract

improve patient experience, reduce radiation expo-

from the prognostic value of MPI. It has been previ-

sure, and optimize resource use. Speciﬁcally, stress-

ously demonstrated that normal stress-ﬁrst studies

ﬁrst imaging has been shown to reduce radiation

carry similar prognostic value in patients with normal

Stress-ﬁrst

protocols

have

been

adopted

exposure to patients by 25% to 80% (16,17), and

stress-rest studies (16,17,25). Selective omission of

technologists and nurses by 40% to 50% (18). As the

rest imaging in these patients would be beneﬁcial in

current radiation reduction goal of ASNC is to reduce

reducing image acquisition, processing time, and

median doses to <9 mSv (9), and a combination of

interpretation time, and it requires lower radiation

stress-only imaging with CZT cameras is shown to

dosing to the patient.

achieve radiation reduction to 1 mSv (19,20), such

STUDY LIMITATIONS. This model was derived in a

protocols will assist in minimizing patient harm and

single-center SPECT cohort, and thus the population

meeting these goals (21). By minimizing the need for

and prevalence of CAD may differ from the popula-

rest imaging, this would potentially reduce cost and

tion at other centers. Although this model can be used

allow for increased patient throughput as well (16,17).

to predict those more likely to have normal MPI, it

The indiscriminate use of a stress-ﬁrst protocol for

does not identify those who may be subject to artifact

all-comers may be difﬁcult and may potentially

or incomplete attenuation compensation whereby

inconvenience

rest images are still required.

patients,

and

depending

on

the

prevalence of CAD in the population, it could require
a signiﬁcant proportion to return a second day for

CONCLUSIONS

rest imaging. Therefore, a stress-ﬁrst protocol would
most greatly beneﬁt those who will most likely have

A novel model, based on easily obtained clinical

a normal MPI. Our model can select patients using

variables, is proposed to identify patients with low

easily obtainable clinical information and could be

probability of having abnormal MPI results. This

calculated at the time of scheduling or even at the

point-of-care tool may be used to identify a popula-

point of care. Another group has examined a model

tion that might qualify for stress-ﬁrst MPI protocols.

to identify eligible patients for stress-ﬁrst studies
(22). Their study reported a sensitivity and speci-

ADDRESS FOR CORRESPONDENCE:

ﬁcity of 57% and 88% in identifying unsuccessful

Chow, University of Ottawa Heart Institute, Division of

Dr. Benjamin

stress-ﬁrst protocols, with the investigators com-

Cardiology, 40 Ruskin Street, Room 1220A, Ottawa,

menting on its cumbersome nature and demon-

Ontario K1Y 4W7, Canada. E-mail: bchow@ottawaheart.ca.

strating that it is only marginally more accurate than
triaging patients based on CAD status alone (23).

PERSPECTIVES

Another shortcoming of this prediction score was the
assignment of 5 points to male sex, which placed all

COMPETENCY IN PATIENT CARE AND PROCEDURAL

men in an intermediate risk group. The investigators

SKILLS: There is an increasing desire to use stress-only or

circumvented this limitation by assigning 4 points to
men. Our study separated analyses according to sex,
in light of growing awareness on differences in
presentation, management, and prognosis between
sexes (24). Furthermore, previous studies incorporated variables that may not be immediately available, such as an abnormal electrocardiography and
congestive heart failure status, and included 1,996

stress-ﬁrst SPECT MPI where possible. Adoption of these protocols have the advantage of reducing radiation exposure,
improving workﬂow, improving patient experience, and reducing
health care costs, without compromising diagnostic accuracy.
Identifying patients that would potentially beneﬁt from a stressﬁrst protocol would allow labs to achieve these goals.
TRANSLATIONAL OUTLOOK: This study developed a simple

patients in their derivation cohorts. The model pre-

point-of-care method of identifying patients that may beneﬁt

sent here was developed to be easily applied at point

from a stress-ﬁrst study. With the use of electronic medical re-

of care (e.g., by booking staff or implemented into

cord information, there may be the future ability to create more

an electronic ordering system) using readily avail-

accurate models, using other variables available within the

able clinical variables at time of booking and was

electronic medical records, such as electrocardiography, creati-

derived with a very large cohort of 18,389 patients,

nine, biomarkers, antecedent test results, and comorbidities.

which is much more robust in terms of sample size.

Integration of such models into an electronic medical record

As well, it was validated in 3 large cohorts across

would improve patient selection and patient care.

both sexes, demonstrating that it is robust across a
diverse patient population.
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